In the Brain & Breathing Science lab, we are working on new approaches to identify novel drug therapies to reduce the impact of coronavirus on health. Using models of coronavirus infection in larval zebrafish, we aim to accelerate drug discovery of new antiviral drugs.
Translational Approach to Identification of Antiviral Drugs for COVID-19
Drug Discovery and Validation using Larval Zebrafish to Accelerate Drug Screening
Our aim is to accelerate drug discovery and preclinical studies by selecting FDA-approved drug library containing potential antiviral drugs
High-throughput Screening Approach using larval zebrafish
Using high-throughput screening approach in larval zebrfish, we can screen hundreds of new drug candidates that can reduce morbidity and mortality due to coronavirus
